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The Mre11 complex (Mre11, Rad50, and Nbs1) is in-
tegral to both DNA repair and ataxia telangiectasia
mutated (ATM)-dependent DNA damage signaling.
All three Mre11 complex components are essential
for viability at the cellular and organismal levels.
To delineate essential and non-essential Mre11 com-
plex functions that are mediated by Nbs1, we used
TALEN-based genome editing to deriveNbs1mutant
mice (Nbs1mid mice), which harbor mutations in the
Mre11 interaction domain of Nbs1. Nbs1mid alleles
that abolished interaction were incompatible with
viability. Conversely, a 108-amino-acid Nbs1 frag-
ment comprising the Mre11 interface was sufficient
to rescue viability and ATM activation in cultured
cells and support differentiation of hematopoietic
cells in vivo. These data indicate that the essential
role of Nbs1 is via its interaction with Mre11 and
that most of the Nbs1 protein is dispensable for
Mre11 complex functions and suggest that Mre11
and Rad50 directly activate ATM.
INTRODUCTION
The DNA damage response (DDR) is important for maintaining
genomic integrity. It comprisespathways thatmediateDNArepair,
DNA damage signaling, cell-cycle regulation and apoptosis.
Impairment of the DDR is associated with diverse human pathol-
ogies such as cancer, neurodegenerative disorders, immune defi-
ciency, and premature aging (Ciccia and Elledge, 2010).
The Mre11 complex—Mre11, Rad50, and Nbs1 (Xrs2 in
S. cerevisiae)—influences all aspects of the DDR via its role as
DNA double-strand break (DSB) sensor as well as its enzymatic
and structural roles in DSB repair (Stracker and Petrini, 2011).
Each member of the complex has been identified as the under-
lying basis of chromosome instability syndromes associated
with immunodeficiency, radiosensitivity, cell-cycle checkpoint
defects, and cancer predisposition (Stracker and Petrini, 2011).
These disorders each exhibit decrements in ataxia telangiectasia496 Cell Reports 18, 496–507, January 10, 2017 ª 2017 The Author(s
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the Mre11 complex is required for the activation of ATM. This
conclusion is supported by biochemical and genetic analyses
in mice, yeast, and human cells (Cerosaletti and Concannon,
2004; Difilippantonio et al., 2005; Schiller et al., 2012; Shull
et al., 2009; Stracker et al., 2008; Theunissen et al., 2003; Waltes
et al., 2009; Williams et al., 2002).
Whereas Mre11 and Rad50 orthologs are present in Bacteria,
Archaea, and Eukaryota, Nbs1 appears to be restricted to Eukar-
yota. Accordingly, the protein appears to influence functions that
are unique to eukaryotic cells. Unlike Mre11 and Rad50, Nbs1
does not appear to bind DNA, nor does it specify enzymatic activ-
ities relevant toDNA repair. Nbs1primarily influencesMre11com-
plex functionbymediatingprotein interactionsvia itsN-andC-ter-
minal domains that influence DNA repair, subcellular localization,
and ATM-dependent checkpoint and apoptotic functions (Cero-
saletti and Concannon, 2003; Desai-Mehta et al., 2001; Larsen
et al., 2014; Lloyd et al., 2009; Saito and Kobayashi, 2013;
Stracker and Petrini, 2011;Williams et al., 2008). Themechanistic
basis for Mre11-complex-dependent ATM activation remains un-
clear. It is notable that the appearance of Nbs1 in eukaryotes co-
incides with theMre11 complex’s role in promoting DNA damage
signaling, as does the Mre11 domain with which Nbs1 interacts.
The Mre11 interaction interface of Nbs1 is a bipartite structure
comprising Mid1 and Mid2 (Mre11 interaction domain) that is
conserved among Nbs1 orthologs (Schiller et al., 2012).
Having previously established that the N and C termini alone
and in combination are dispensable for ATM activation (Stracker
and Petrini, 2011), we undertook mutagenesis of the Mre11-
Nbs1 interface with the goal of impairing the Nbs1-Mre11 inter-
action while leaving the Nbs1 protein otherwise intact in an effort
to define the role of Nbs1 in ATM activation. Using transcription
activator-like effector nuclease (TALEN)-based genome editing,
we created an allelic series in mice consisting of six mutations
(Nbs1mid) within Mid2 that impair the interaction between Nbs1
and Mre11 to varying degrees. The most severe mutants abol-
ished the Mre11-Nbs1 interaction, which resulted in the loss of
cellular and organismal viability. These data indicate that the
Mre11-Nbs1 interaction is essential, and therefore required, for
ATM activation.
Complementation of Nbs1-deficient cells with Nbs1 fragments
spanning Mid1 and Mid2 rescued the viability of cultured cells).
commons.org/licenses/by/4.0/).
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Figure 1. The NFKxFxK Motif in Nbs1 Is
Essential for Mouse Embryogenesis
(A) Schematic structure of mammalian Nbs1 pro-
tein and sequence alignment of Mre11-interacting
domain 1 and 2 among different species. Invari-
able residues are shown in black boxes. FHA,
BRCT, and AIM denote forkhead-associated
domain, BRCA1 C-terminal domain, and ATM-
interacting motif, respectively.
(B) Sequence of Nbs1mid mutant alleles created
by TALEN-mediated gene editing. Nbs1mid7c is a
truncated mutant allele.
(C) Mre11 interaction of different Nbs1mid mutants
was assessed by immunoprecipitation (IP) by
FLAG antibodies followed by western blot for
Mre11. FLAG-tagged WT or mutant full-length
Nbs1 was transiently expressed in MEFs. FLAG
peptide (100 mg/mL) was added to theWT sample
during IP for a FLAG IP control.
(D) Intercrosses of heterozygousNbs1midmutants.
Numbers of pups born are indicated and expected
numbers are shown in parenthesis.and hematopoietic cells in vivo. Cells rescued in this manner also
exhibited some indices of ATM function. In vitro, the Nbs1 frag-
ments that rescued viability promoted Mre11 dimerization and
DNA binding. In addition, they restored the ability of CtIP to
activate Mre11 endonuclease activity, a function shown to be
dependent on Nbs1. Collectively, these data suggest that the
Nbs1-Mre11 interaction is required for proper assembly of the
Mre11 complex. Accordingly, that interaction is required for
the concerted activities of Mre11 and Rad50 that govern DNA
repair and DNA damage signaling and promote viability.
RESULTS
The Evolutionarily Conserved NFKxFxK Motif in Nbs1 Is
Essential for Mouse Embryogenesis
Themammalian Nbs1 protein interacts with Mre11 via a bipartite
domain near the C terminus, comprising Mid1 and Mid2
(Figure 1A). Mid2 includes a highly conserved NFKxFxK motif,
whereas Mid1 is characterized by a single conserved leucineCell Rat position 648 of the mouse protein (Fig-
ure 1A). We carried out mutagenesis of
the NBS1 cDNA to identify alleles that
weakened the Nbs1-Mre11 interaction.
Mutation of L648 had a minimal effect
on the Mre11-Nbs1 interaction, whereas
the interaction was severely impaired by
mutation of F686 in Mid2 (Figure 1C). On
that basis, we carried out TALEN-based
gene editing in mice to induce small dele-
tions within Mid2 and thereby compro-
mise the interaction between Mre11 and
Nbs1 (Figure S1A).
We generated seven new Nbs1mid
mutant mice (Nbs1mid1, Nbs1mid2,
Nbs1mid3, Nbs1mid4, Nbs1mid5, and
Nbs1mid8) in which the NFKxFxK motif ofMid2 is altered (Figure 1B). The genomic sequences of Nbs1
Exon 13 from founder mutant lines are listed (Figure S1B). These
mutations were modeled in cDNA expression constructs. The
ability of the corresponding protein products to interact with
Mre11 was assessed by co-immunoprecipitation. Nbs1mid1
was indistinguishable from WT, whereas Mre11 interaction was
moderately (Nbs1mid3 and Nbs1mid4) to severely impaired
(Nbs1mid5 and Nbs1mid8) (Figure 1C). The binding of Nbs1mid2 is
similar to that of wild-type protein (data not shown). Whereas
Nbs1mid1/mid1, Nbs1mid2/mid2, Nbs1mid3/mid3, and Nbs1mid4/mid4
mice were born at expected Mendelian frequencies, homozy-
gosity for either Nbs1mid5 or Nbs1mid8mutations was lethal, indi-
cating that theMre11-Nbs1 interaction is essential for embryonic
viability (Figure 1D).
Disruption of the Mre11-Nbs1 Interaction Compromises
DDR and Promotes Tumorigenesis
The extent to which the Nbs1-Mre11 interaction was impaired
scaled with the phenotypic severities observed. We assessedeports 18, 496–507, January 10, 2017 497
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Figure 2. The Mre11-Nbs1 Interaction Is Important for DDR and Tumor Suppression
(A) IR-induced ATM signaling in WT, Nbs1mid1, Nbs1mid2, Nbs1mid3, and Nbs1mid4 thymocytes. ATM signaling was assessed by western blot for the phos-
phorylation of KAP1 (S824) and hyperphosphorylation of Chk2, which are ATM substrates. Note that Chk2 migrates slowly when hyperphosphorylated.
(B) Mouse tumor free survival. Each data point represents the percent survival of mice with each genotype at a given age. N denotes total number of mice for each
genotype and the average age in death in days is shown. p value of double mutants compared to p53/ was determined by Wilcoxon rank sum test (**p < 0.01
and ***p < 0.001).
(C) ATM signaling in Nbs1/mid5 MEFs was assessed by western blot for phospho-ATM (S1981) and the phosphorylation of ATM substrates, KAP1 (S824), and
Chk2. The asterisk indicates nonspecific band.
(D) Colony-formation assay to assess cell viability of Nbs1/mid5 and Nbs1/mid8 alleles in MEFs.
(E) Nuclei were stained with DAPI (40,6-diamidino-2-phenylindole).
(F) The percentage of nuclei with micronuclei was counted from randomly taken images (mean ± SD, 100 < number [N] from seven images). p value was
determined by unpaired t test (***p < 0.001).
(G) Representative chromosome metaphase images of Nbs1/mid5 and Nbs1/mid8 MEFs.
(H) Percentage of metaphases with aberrations (***p < 0.001, Fisher’s exact test, more than 40 metaphases).the effects ofNbs1midmutations on ATM activation by examining
phosphorylation of the ATM substrates Kap1 (S824) and Chk2
following ionizing radiation (IR). In homozygous Nbs1mid1 and
Nbs1mid2 cells, those endpoints were indistinguishable from
WT, whereas Nbs1mid3 and Nbs1mid4 homozygotes exhibited
defects in phosphorylation (Figure 2A). Those mutants also ex-
hibited defects in the G2/M checkpoint, indicative of reduced
ATM activation. At 1 hr following treatment with 3 Gy IR, the
mitotic index ofWT cells decreased by 85%–87% (Figure S2A),
whereas the decrease was only 64% for Nbs1mid3/mid3 and 72%
for Nbs1mid4/mid4, consistent with the more severe impairment
of Kap1 and Chk2 phosphorylation in Nbs1mid3/mid3 than
Nbs1mid4/mid4. Similarly, colony-formation assays indicated that
IR resistance was reduced in Nbs1mid3/mid3 and Nbs1mid4/mid4
cells (Figure S2B).498 Cell Reports 18, 496–507, January 10, 2017The defects imparted by Nbs1mid3 and Nbs1mid4 increased
cancer risk. In our colony, p53-deficient mice present with
thymic lymphoma at 180 days of age. Over a 10-month
time course, Nbs1mid3/mid3 and Nbs1mid4/mid4 mice did not
present with malignancy (data not shown); however, when
combined with p53 deficiency, the mean tumor-free survival
decreased by 27–50 days relative to p53/ mice (***p <
0.001; Nbs1mid3 p53/ vs. p53/ and **p < 0.01; Nbs1mid4
p53/ vs. p53/) (Figure 2B). In addition to reduced latency,
the spectrum of tumors arising in double-mutant mice
expanded to include leiomyosarcoma, squamous cell carci-
noma, hemangiosarcoma, rhabdomyosarcoma, and histiocytic
sarcoma (Table S1). We propose that destabilization of the
Mre11-Nbs1 interface impairs ATM activation and modifies
the p53/ phenotype.
We were unable to establish embryonic fibroblasts homozy-
gous for the Nbs1mid5 or Nbs1mid8 alleles. To define the cellular
phenotypes of Nbs1mid5 and Nbs1mid8, these mice were crossed
with Nbs1F mice in which cre expression inactivates NBS1
(Demuth et al., 2004). Following transduction of a tamoxifen
(4-OHT)-regulated cre recombinase into immortalized mouse
embryonic fibroblasts (MEFs) from Nbs1F/mid5 and Nbs1F/mid8
mice, 4-OHT was added to the media for 24 hr. cre-mediated
deletion of Nbs1F was evident within 24–48 hr (data not shown),
and the remaining Nbs1mid5 and Nbs1mid8 proteins were present
at markedly reduced levels, whereas Mre11 and Rad50 levels
were unchanged (Figures 2C and S2C). Colonies of Nbs1/mid5
or Nbs1/mid8 MEFs were not recovered (Figure 2D), indicating
that as in the case of mouse embryos, the Mre11-Nbs1 interac-
tion is essential. 4 days following the induction of cre activity
(prior to cell death), indices of genome destabilization were
evident in both Nbs1/mid5 or Nbs1/mid8 cells, including micro-
nuclei and chromosome aberrations (Figures 2E–2H). These
outcomes resemble those observed upon genetic ablation of
RAD50, MRE11, or NBS1 (Adelman et al., 2009; Buis et al.,
2008; Reina-San-Martin et al., 2005).
ATM activation was assessed in Nbs1/mid5 and Nbs1/mid8
cells at 4 days following cre. IR-induced Kap1 S824 and Chk2
phosphorylation were nearly undetectable in Nbs1/mid5 (Fig-
ure 2C) and severely attenuated in Nbs1/mid8 cells (Figure
S2C), suggesting that impairing the Mre11-Nbs1 interaction
compromised ATM activation. Accordingly, IR-induced ATM
S1987 autophosphorylation, a direct index of ATM activation
(Bakkenist and Kastan, 2003; Paull, 2015), was also sharply
decreased inNbs1/mid5 cells relative toNbs1F/mid5 controls (Fig-
ure 2C). As expected, both Nbs1mid5 and Nbs1mid8 alleles exhibit
defects in the G2/M checkpoint that were considerably more se-
vere than those observed inNbs1mid3/mid3 orNbs1mid4/mid4 alleles
(Figure S2D). These assessmentsmay underestimate the severity
of theNbs1/mid5 andNbs1/mid8 phenotypes due to the possible
presence of residual Nbs1 protein.
The Nbs1 Minimal Fragment Rescues Nbs1 Deficiency
Previously, a C-terminal truncation of 100 amino acids of human
Nbs1 that includedMid1 andMid2 was unable to rescue viability
of Nbs1-deficient mouse cells (Difilippantonio et al., 2005). Data
presented here indicate that the presence of an essentially com-
plete Nbs1 protein that is unable to interact with Mre11 was not
sufficient for viability or ATM activation. Given that the N and C
termini are dispensable, singularly or in combination, for cell
viability and ATM activation (Stracker and Petrini, 2011) (data
not shown), we used deletional mutagenesis to define the ‘‘min-
imal Nbs1’’ required to support viability.
Three Nbs1 gene segments encoding N-terminal truncation
fragments, all of which also lacked the C-terminal 24 amino acids
of Nbs1, were constructed in a retroviral expression vector. The
constructs encoded fragments of 388, 188, and 108 amino acids
(F2, F3, and F4, respectively) fused to a FLAG epitope and SV40
nuclear localization signal (NLS) at their N termini for nuclear
localization (Figure 3A). The Nbs1 gene segments were trans-
duced into Nbs1F/F MEFs, and the ability of the encoded frag-
ments to interact with Mre11 was assessed via FLAG immuno-
precipitation. All fragments co-immunoprecipitated with Mre11andRad50 (Figure 3B).Moreover, F4which spans just 108 amino
acids inclusive of Mid1 andMid2 displaced full-length Nbs1 from
Mre11 and Rad50, arguing that Nbs1 is unlikely to interact with
other domains of the Mre11 complex (Figure 3B).
Subsequently, cre activity was induced with 4-OHT, and the
ability of fragment-containing cells to form colonies was as-
sessed. Whereas no colonies formed from control (vector-trans-
duced) cells, all of the cells expressing F2, F3, and F4 were able
to form colonies after 10 days in culture. PCR genotyping and
western blot confirmed that the introduced fragments were the
sole source of Nbs1 protein remaining in the Nbs1/ cells—
the fragments are hereafter designated ‘‘rescue fragments’’ (Fig-
ures S3A–S3C). By cloning the cells in this manner and by
propagation in culture over the course of several weeks, any
contribution from residual Nbs1-proficient (Nbs1F) cells to col-
ony formation or subsequent phenotypic assessments was
excluded. These data indicated that as few as 108 amino acids
of Nbs1 spanning the Mre11-Nbs1 interaction interface are
sufficient to sustain the viability of cultured cells.
In addition to sustaining viability, the rescue fragments were
able to promote ATM activation in Nbs1/ cells. The pheno-
types of Nbs1-fragment-expressing cells were compared to a
culture of Nbs1F/F cells at 4 days after cre induction. Whereas
Kap1 S824 phosphorylation was sharply reduced at 0.5 hr after
5 Gy IR in Nbs1/, it was readily evident in F2- and F3-contain-
ing cells and, to a lesser extent, in F4 cells (Figure 3C). IR-
induced Kap1 S824 phosphorylation of F4 cells was confirmed
as ATM-dependent activity by pretreatment with an ATM inhibi-
tor (Figure S3D). Those complemented cells exhibited restora-
tion the G2/M checkpoint. After 1 hr following treatment with
3 Gy IR, the mitotic index of F2-, F3-, and F4-containingNbs1/
cells decreased by 68%, 66%, and 44%, respectively, while the
decrease was only 14% for ATM/ cells (Figure 3D). These data
indicate that a substantial degree of ATM-dependent checkpoint
function was retained in rescue-fragment-expressing cells. A
fragment of human Nbs1 spanning residues 401–754 was previ-
ously shown to suppress ATM activation and nuclear localization
defects in Nijmegen breakage syndrome (NBS) patient cells
(Cerosaletti and Concannon, 2004).
To obtain a quantitative assessment of DDR function in
rescue-fragment-containing cells, the frequency of spontaneous
chromosome aberrations was assessed. 100% of Nbs1/ cells
exhibit widespread chromosome fragility, with more than three
aberrations per metaphase spread (Figures 3E and 3F). In
contrast, fewer than 21% of F2-, F3-, and F4-containing cells
exhibited three or more aberrations (Figure 3F), indicating a
substantial degree of residual function.
Nevertheless, rescue-fragment-expressing cells did not phe-
nocopy cells expressing wild-type Nbs1. We observed sharply
reduced nuclear localization of Mre11 in F4-containing cells rela-
tive to F2 or F3-containing cells (Figure 3G), likely accounting for
reduced Kap1 phosphorylation in F4-containing cells. Data from
budding yeast and human cells indicate that Xrs2 and Nbs1 are
required for nuclear localization of Mre11 and Rad50 (Cerosaletti
and Concannon, 2004; Cerosaletti et al., 2006), and enforced nu-
clear localization ofMre11 inS. cerevisiae partially restored func-
tion to xrs2D mutants (Oh et al., 2016; Tsukamoto et al., 2005).
F4-containing cells were more sensitive to IR than F2 cellsCell Reports 18, 496–507, January 10, 2017 499
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Figure 3. The Nbs1 Minimal Fragment Rescues Nbs1 Deficiency
(A) Structure of Nbs1 fragments used in rescue experiments. Domains are indicated in Figure 1A.
(B) Mre11 interaction of Nbs1minimal fragments. FLAG-tagged Nbs1 fragments (F2, F3, and F4) were expressed inNbs1F/FMEFs, and immunoprecipitation with
FLAG antibodies was performed followed by western blot for Mre11, Rad50, and Nbs1.
(C) IR-induced ATM signaling in Nbs1/ MEFs expressing Nbs1 minimal fragments. As an ATM substrate, phosphorylation of KAP1 (S824) was assessed.
(D) IR-induced G2/M cell-cycle checkpoint of Nbs1/ MEFs expressing Nbs1 minimal fragments. Mitotic cells were detected by measuring mitosis-specific
phosphorylation of histone H3 (Ser10).ATM/MEFs was used for controls. p value was determined by unpaired t test (**p < 0.01, mean ± SD, three independent
experiments).
(E and F) Metaphase spread of Nbs1/MEFs expressing Nbs1 minimal fragments. (E) Representative chromosomemetaphase images of Nbs1F/F and Nbs1/
MEFs. (F) The graph indicates the percent ratio of metaphases with aberrations (**p < 0.01 and ***p < 0.001, Fisher’s exact test, more than 65 metaphases from
two independent experiments).
(G) Immunofluorescence cell staining of Mre11 in Nbs1/MEFs expressing Nbs1 minimal fragments. Nuclei are shown by DAPI (40,6-diamidino-2-phenylindole)
staining.
(H) Immunofluorescence cell staining of Rad50 and Mre11 in Nbs1/ MEFs expressing Mre11-NLS. Nbs1/-Mre11-NLS cells were achieved by treating
Nbs1F/FcreERT2-Mre11-NLS cells with 4-OHT treatment. Cells were stained at day 3 after 4-OHT treatment. Nuclei are shown by DAPI (40,6-diamidino-2-
phenylindole) staining.
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(Figure S3E), and we reasoned that a contributing factor to the
reduced efficiency of F4-dependent restoration of ATM activa-
tion might be aberrant localization of Mre11 and Rad50. To
determine whether enforced nuclear localization of Mre11
would mitigate the effects of Nbs1 deficiency, we expressed
an SV40 NLS-Mre11 cDNA (Mre11-NLS) in Nbs1F/F cells. No
viable Nbs1/ Mre11-NLS-expressing cells were recovered at
3 weeks, and at 4 days after cre induction, Mre11-NLS did not
restore IR-induced G2/M checkpoint functions (Figure S4).
Consistent with data from human NBS cells (Lakdawala et al.,
2008), enforced nuclear localization of Mre11 in Nbs1/ cells
did not restore nuclear localization of Rad50 (Figure 3H).
Biochemical Effects of the Nbs1 Minimal Fragment
These data suggested that Nbs1 influences the stability and as-
sembly of the Mre11 complex in addition to its subcellular local-
ization. To test this interpretation, we examined the effect of hu-
man Nbs1 F4 on the biochemical properties of Mre11 in vitro.
The human Mre11 core (1–411 amino acids) (Park et al., 2011)
was purified and subjected to size exclusion chromatography.
Individually, Mre11 and Nbs1 F4 fused to a maltose-binding pro-
tein (F4-MBP) primarily appeared as single, monomeric peaks
(apparent molecular weight [MW]: 42 kDa for Mre11 and
59 kDa for F4-MBP). When mixed at a 1:1 ratio, we observed a
new peak with an apparent molecular weight of 184 kDa, consis-
tent with the co-elution of Mre11 and Nbs1 dimers (i.e., two F4-
MBP and two Mre11 cores) (Figures 4A and 4B). The new peak
was not observed in F4-mid5-MBP in which the NFKKFKK motif
is deleted (Figure S5).
F4-MBP also stimulated DNA binding by the Mre11 core.
Mre11 binds DNA as a dimer (Williams et al., 2008). We found
that the binding of Mre11 to double-stranded DNA (dsDNA) (Fig-
ure 4C) or a hairpin (Figure 4D) substrate was stimulated by Nbs1
F4 in electrophoretic mobility shift assays (EMSAs). Supershift-
ing induced by MBP antisera confirmed that the Mre11-DNA
complex contains Nbs1 (Figure 4D).
We next examined the effect of F4-MBP on Mre11 nuclease
activity. Phosphorylated CtIP has recently been shown to pro-
mote Mre11 endonuclease in a manner that depends on Nbs1
(Anand et al., 2016). The Mre11-Rad50 complex was incubated
with a 70-bp radiolabeled dsDNA substrate, the ends of which
were blocked by streptavidin to prevent exonucleolytic degrada-
tion (Figure 4E). In the absence of F4-MBP, or in the presence of
the non-interacting F4-mid5-MBP fragment (Figure 4F), CtIP did
not promote endonucleolytic cleavage byMre11 (Figures 4G and
4H). In contrast, wild-type F4-MBP with phosphorylated CtIP
promoted the endonuclease of Mre11-Rad50 (Figure 4H).
To further examine the hypothesis that Nbs1 mediates proper
assembly of Mre11 and Rad50, we carried out scanning force
microscopy (SFM). Previous SFM analysis revealed a stoichiom-
etry of two or four Nbs1 proteins per M2R2 complex (van der
Linden et al., 2009). However, the addition of two or four Nbs1
proteins to the globular domain of M2R2 obscured possible
structural rearrangement. The minimal Nbs1 fragment identified
here allowed analysis of Mre11 changes in complex architecture
by SFM imaging. The M2R2 complex is characterized by a single
globular domain (Mre11 + Rad50 ATPase domains) with two pro-
truding coiled coils (Figure 5A). The coiled coils are usually apartbut 32% of the time appear to be linked by the zinc-hook do-
mains at their apexes (de Jager et al., 2004; Moreno-Herrero
et al., 2005).
To assess the effect of F4 on Mre11 complex assembly, the
full-length human M2R2 complex was incubated at a 1:1 molar
ratio with F4-MBP or F4-mid5-MBP (non-binding mutant)
before imaging. A striking rearrangement of the Mre11 globular
domain was induced in the presence of the F4 peptide, with the
globular domain appearing as two distinct but linked globular
objects (Figure 5B). The proportion of Mre11 complexes with
this conformation increases from 12% to 58% in the presence
of the F4 peptide but does not significantly change in the pres-
ence of the control F4-mid5 peptide (Figure 5C). This separa-
tion into two distinct globular objects is accompanied by an in-
crease in width of the globular domain (Figure 5D), consistent
different conformations of related Mre11 complexes captured
in X-ray crystallography studies (Wyman et al., 2011). Incuba-
tion with the F4 peptide also notably changed the conformation
of the coiled coils. In the presence of the F4 peptide, Mre11
complexes exhibited a notable increase in complexes with
coiled coils linked via the zinc-hook apexes (Figures 5E and
5F). These data suggest that that Nbs1 influences nanoscale
arrangement of Rad50 and Mre11 globular domains with
consequent influence on conformational flexibility of the
Rad50 coiled coils favoring dimerization of the zinc hooks.
Collectively, these data strongly support the view that Nbs1’s
influence on the physical disposition of the Mre11 complex
constitutes its essential function and that this influence under-
lies its requirement for nuclear localization, cell viability, and
ATM activation.
Nbs1/ Fetal Liver Cells Reconstitute the
Hematopoietic System upon Nbs1 Minimal Fragment
Expression
Immortalized cells are likely more tolerant of genotoxic stress
than constituents of tissues in vivo. To determine whether the
rescue fragments would sustain viability in vivo, we assessed
their ability to support the differentiation of lymphocytes. Previ-
ous analyses indicated that the Mre11 complex is required for
lymphocyte development (Balestrini et al., 2016; Calle´n et al.,
2007; Deriano et al., 2009; Reina-San-Martin et al., 2004).
Nbs1F/F mice were crossed to vavCre mice, which express cre
recombinase in hematopoietic stem cells (HSCs) (Stadtfeld and
Graf, 2005). Hematopoietic Nbs1 deficiency resulted in perinatal
lethality due to lack of bone marrow development (Figure S6).
Fetal liver cells (FLCs) from embryonic day 13.5 (E13.5) em-
bryos were isolated and transduced with Nbs1 rescue fragment
encoding in an IRES-GFP murine stem cell virus (MSCV) retro-
virus prior to transplantation into lethally irradiated mice as
depicted (Figure 6A). At 10 weeks after transplantation, spleen
was isolated and assessed for GFP-positive cells. Although we
did not observe complete reconstitution, GFP-positive, B220-
positive cells comprised 6% of splenocytes (Figure 6B). The per-
centages of GFP-positive, B220-positive cells may underesti-
mate thedegree of reconstitution by rescue-fragment-containing
HSCs due to silencing of the MSCV retrovirus during hematopoi-
etic differentiation as observed previously (Cherry et al., 2000).
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Figure 4. The Nbs1 Minimal Fragment Promotes Mre11 Dimer Formation, Mre11 DNA Binding, and Nuclease Activity
(A) Gel filtration of theMre11 and Nbs1 complex by Superdex 200 in the presence of 1mMMnCl2. An equimolar mixture of humanMre11 (1–411 amino acids) and
Nbs1 (F4) protein was used at 0.5 mM.
(B) Elution traced of a gel filtration experiment. Molecular weight was estimated by a gel filtration standard. Arrowheads indicate higher molecular weight
complex; Mre11/Nbs1 dimers (closed) and Mre11 dimer (open).
(C and D) DNA binding ofMre11. Electrophoretic mobility shift assay (EMSA) was performed using purified humanMre11 (1–411 amino acids, 1 mMand 5 mM) and
Nbs1 (F4, 5 mM) proteins with 10 nM of end-labeled double-stranded (C) or hairpin (D) DNA probe. Supershift was performed using 1 mgMBP antibody. All EMSA
reactions were performed in the absence of Mn2+.
(E) Mre11 endonuclease assay probe. The 30 end-labeled 70-bp dsDNA is blocked at both ends with streptavidin.
(F) Amylose pull-down assay for Mre11 binding of F4 and F4-mid5 protein. An equimolar mixture of humanMre11 (1–411 amino acids) and Nbs1 (MBP-F4-WT or
MBP-F4-mid5) protein was incubated with amylose resin at 1 mM in the presence of 1 mMMnCl2, and the interaction was visualized by Coomassie-blue-stained
SDS-PAGE.
(G and H) Endonuclease assay with Mre11/Rad50/phosphorylated CtIP with F4-mid5 (G) or F4-WT (H). M, R, and pCtIP denote Mre11, Rad50, and phos-
phorylated CtIP, respectively.(Adelman et al., 2009); hence, silencing of F4 expression may be
tolerated because splenocytes are largely quiescent.
PCR genotyping confirmed that recipient mice contain differ-
entiated cells derived from Nbs1 fragment containing Nbs1/
FLCs and that the fragment-encoding construct is present; the
Nbs1F allele was not detected (Figure 6C). This confirms that
this rescue is not by remaining undeleted Nbs1F allele in donor
FLCs. No reconstitution was observed in control mice trans-
duced with FLCs lacking the rescue fragments (data not shown).
These data indicate that as with transformed cells, the 108 amino502 Cell Reports 18, 496–507, January 10, 2017acids spanning the Mre11 interaction interface of Nbs1 (F4; Fig-
ure 3A) are sufficient to promote viability in vivo and, moreover,
that minimal Nbs1 fragment was sufficiently functional to sup-
port differentiation of HSCs into splenic B cells.
DISCUSSION
To examine the role of Nbs1 in Mre11 complex functions, we un-
dertook mutagenesis of Nbs1 in an attempt to weaken the inter-
action with Mre11 and thereby examine the functionality of the
AB
D
E F
C Figure 5. The Nbs1 Minimal Fragment
Causes Rearrangement of MR Architecture
(A and B) SFM image examples of MR complexes
appearing with one globular domain (A) or ap-
pearing with globular domain with two distin-
guishable parts (B).
(C) Distribution of MRmolecules based on globular
domain arrangement, alone and in the presence of
Nbs1 F4-WT or -mid5.
(D) The two forms of MR illustrated in (A) and (B)
can be distinguished based on the width of their
globular domain. The width for molecules with one
globular domain and two distinct linked globular
domains is plotted (average of n = 66 and n = 92,
respectively, ± SD).
(E) SFM image examples of coiled-coil arrange-
ments classified for complexes with two distinct
linked globular domains (scale bar, 20 nM).
(F) Distribution of the coiled-coil arrangement
among MR complexes with two distinct linked
globular domains, alone and in the presence of
Nbs1 F4-WT or -mid5.
M and R denote Mre11 and Rad50, respectively.core Mre11-Rad50 complex disassociated from Nbs1. Muta-
tions that disrupted Mre11 interaction caused inviability. Hence,
the presence of a non-interacting but otherwise intact Nbs1 pro-
tomer was not sufficient for viability, establishing that Nbs1 inter-
action per se is essential. Conversely, we found that 108 amino
acids of Nbs1 spanning the Mre11 interaction domain were
sufficient to promote cell viability. Although ATM activation
was reduced in that setting, it was not abolished. Collectively,
the data strongly argue that ATM activation is not directly depen-
dent on Nbs1. Instead, we propose that essential functions of
Nbs1 are to ensure proper assembly and subcellular localization
of the Mre11 complex, which in turn promotes viability and influ-
ences ATM activation by Mre11 and Rad50.
The Role of Nbs1 in the Mre11 Complex: Essential
Functions
Nbs1 clearly mediates essential as well as non-essential func-
tions. With respect to the former, the data presented here indi-
cate that the Mre11-Nbs1 interaction is specifically required
for cellular and organismal viability. The levels of Mre11 and
Rad50 protein were not changed inNbs1midmutant cells. Hence,
it is the loss of interaction, rather than global destabilization of
Mre11 complex components that accounts for the loss of
viability in non-interactingNbs1midmutants. Further, this empha-
sizes the fact that Mid2 (the conserved NFKxFxK motif, which
was the target of the TALEN-based mutagenesis) is the majorCell Rdeterminant of Nbs1’s association with
the Mre11 complex. These data are
consistent with the finding that the human
Nbs1tr645 allele in which the C-terminal
100 amino acids of Nbs1 were deleted
was unable to support viability of mouse
embryos (Difilippantonio et al., 2005).
What are the essential functions of
Nbs1 in the Mre11 complex? First, it isclear that the nuclear localization of Mre11 is influenced
by Nbs1, but this does not solely depend on the Mre11 inter-
action domain. Mre11 complex mislocalization is observed
in human NBS and A-TLD cells, as well as in Nbs1DB/DB and
Mre11ATLD1/ATLD1 mouse models of those human mutations,
neither of which harbor alterations in their respective interaction
domains (Carney et al., 1998; Difilippantonio et al., 2005; Reina-
San-Martin et al., 2005; Stewart et al., 1999; Williams et al.,
2002). Nbs1 and Mre11 levels are reduced in those settings,
raising the possibility that the stoichiometry of complex compo-
nentsmay also influence nuclear localization. Alternatively, those
mutations may disrupt as-yet-undescribed interactions required
for nuclear localization.
Nevertheless, promoting nuclear localization of Mre11 and
Rad50 is likely not the only function of Nbs1 required for viability.
Enforced nuclear localization byMre11-NLS could not restore nu-
clear localization of Rad50 in human NBS cells (Lakdawala et al.,
2008), nor did it compensate for Nbs1 deficiency in MEFs (Fig-
ure 3H). The data presented here are most consistent with the
interpretation that Nbs1 influences the assembly and disposition
of the complex. Supporting that view, we showed that dimeriza-
tion and DNA binding by the N-terminal 411-amino-acid core of
Mre11 was enhanced by the F4 fragment (Figures 4A–4D),
although it is likely that dimeric assemblies of full-length Mre11
may exhibit greater stability. Further support comes from the
fact that only in the presence of Nbs1 or the minimal fragment iseports 18, 496–507, January 10, 2017 503
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Figure 6. Hematopoietic Reconstitution by
the Nbs1 Minimal Fragment
(A) Experimental scheme of fetal liver cell trans-
plantation.
(B) Flow cytometry analysis of splenocytes from
recipient mice 10 weeks post-transplantation. For
B cells, B220+ cells were gated from total sple-
nocytes and plotted by GFP signal. Plots shown
here are representative of recipient mice from
each group of Nbs1 fragments.
(C) PCR genotyping of splenocytes for an exoge-
nous Nbs1 fragment, vavCre and Nbs1F allele,
which is donor-FLC specific. Nbs1+/F MEFs were
used for PCR control for the Nbs1F allele. NT de-
notes control mouse.CtIPable tostimulateMre11endonucleolyticcleavage (Figure4H).
Finally, scanning force microscopy analysis reveals that in the
presence of Nbs1 (whether minimal fragment F4 or the full-length
Nbs1 protein), the Mre11-Rad50 complex exhibits substantial
structural differences in the disposition of Mre11 and Rad50 in
the globular domain, the path of the coiled coils, and the associa-
tion of the apical (presumably hook) domains of Rad50. These
physical data resonatewith genetic data indicating thatmutations
in Rad50 exert effects on regions distal to the altered residues (Al-
Ahmadie et al., 2014; Hohl et al., 2011, 2015; Hopfner et al., 2002).
On the basis of these findings, we favor the view that Nbs1 func-
tions as a chaperone to promoteproper assembly of the complex,
which is a prerequisite for its enzymatic and DNA-binding func-
tions as well as for determining its subcellular localization.
The Role of Nbs1 in the Mre11 Complex: Non-essential
Functions
The non-essential functions ofNbs1have been illuminated byge-
netic analyses in humancells andmice.Nbs1containsN-terminal
forkhead-associated (FHA) and BRCA1 C-terminal (BRCT) do-
mains, which are disrupted in the canonical Nbs1657D5 allele in-
herited by NBS patients and the corresponding Nbs1DB allele in
mice. Those mutants exhibit defects in DSB end resection,
DNA repair, and cell-cycle checkpoint activation, presumably
due to the loss of protein interactionsmediated by thosedomains
(Alt et al., 2005; Chapman and Jackson, 2008; Kobayashi et al.,
2002; Larsen et al., 2014; Lloyd et al., 2009; Maser et al., 2001;
Melander et al., 2008; Morishima et al., 2007; Spycher et al.,
2008; Williams et al., 2009; Wu et al., 2008, 2012). However, hu-504 Cell Reports 18, 496–507, January 10, 2017man and mouse cells lacking those
domains are viable and retain the ability
to activate ATM (Difilippantonio et al.,
2005; Williams et al., 2002). Deletion of
the Nbs1 C terminus (the Nbs1DC allele),
which has been reported to bind ATM
(Falck et al., 2005; You et al., 2005),
had no effect on ATM activation or cell
viability but is required for ATM-depen-
dent apoptosis (Stracker et al., 2007).
The Nbs1DBC allele is a composite of
the Nbs1DB and Nbs1DC. The outcomes
of Nbs1DB and Nbs1DC are simply addi-tive in Nbs1DBC/DBC mice rather than synergistic; the phenotypic
outcomes attributable to Nbs1DB and Nbs1DC are unchanged in
the composite Nbs1DBC (Shull et al., 2009; Stracker et al., 2007).
Therefore, we propose that Nbs1 serves as a platform for Mre11
complex assembly and the recruitment of ATM substrates to
enhance access of the activated kinase to substrates that govern
ATM- and Nbs1-dependent functions. In this context, we draw a
distinction between ATM activation and ATM activities: in the
former circumstance, a properly assembled and localized com-
plex is required for ATM activation, whereas in the latter, Nbs1
potentiates ATM activity by promoting access of the active
kinase to its downstream effectors.
Although viability and ATM activation are lost upon genetic
ablation of Nbs1, the protein does not appear to influence those
outcomes directly. Rather, its association with Mre11 (and so
Rad50) via its conserved interaction interface appears to influ-
ence both the subcellular localization and the proper assembly
of the Mre11 complex, which in turn accounts for its influence
on viability as well as ATM activation (Figure 7). Indeed, most
of the Nbs1 protein, save for the Mre11 interaction interface, is
dispensable for viability as well as ATM activation. Therefore,
the mechanism(s) underlying ATM activation would appear to
be mediated by Mre11 and Rad50. Notably, ATM appears to
interact with Rad50 in vitro (Lee and Paull, 2005), and recent ge-
netic and biochemical analyses have shown that Rad50 influ-
ences the activation of ATM or its budding yeast ortholog, Tel1
(Al-Ahmadie et al., 2014; Deshpande et al., 2014; Hohl et al.,
2015). These data underlie the speculation that Rad50 is likely
to be the proximal effector of ATM activation.
Figure 7. The Mre11 Interaction Domain of Nbs1 Is Necessary and
Sufficient for Mre11 Complex Functions
Disruption of the Mre11-Nbs1 interaction results in cellular and organismal
lethality and increased tumorigenesis due to a defect in Mre11 complex
function. An Nbs1 minimal fragment spanning just the Mre11-Nbs1 interaction
interface is sufficient to sustain the viability of cells and stabilize Mre11 dimer
and Mre11 DNA binding and nuclease activity. These data indicate an
essential role for Nbs1 is via its interaction with Mre11 and that most of the
Nbs1 protein is dispensable for Mre11 complex functions. Mid1, Mid2, and
AIM denote Mre11-interacting domain 1, Mre11-interacting domain 2, and
ATM interacting motif, respectively.Manipulation of the DDR for therapeutic benefit offers signifi-
cant potential (O’Connor, 2015). Accordingly, understanding of
ATM activation is an important issue. This study thus provides
important mechanistic insight toward that goal by defining the
role of Nbs1 in promoting Mre11 complex functions in the DDR.
EXPERIMENTAL PROCEDURES
For detailed protocols of cell lines, cellular assay, fetal liver cell transplantation,
immunofluorescence staining, and histopathology, see Supplemental Experi-
mental Procedures.
Mice
Nbs1mid mice were generated by help of the Memorial Sloan Kettering Mouse
Genetics core. Detailed protocol will be provided upon request. Nbs1DB mice
were previously described (Williams et al., 2002), and Nbs1F and vavCre mice
were kindly provided by Zhao-Qi Wang (Fritz Lipmann Institute, Germany) and
Hans-Guido Wendel (Memorial Sloan Kettering Cancer Center, USA), respec-
tively. The Institutional Animal Care and Use Committee of Memorial Sloan
Kettering Cancer Center approved all protocols for animal use.
Protein Purification and Analysis
Bacterial expression vector for N-terminal his-tagged human Mre11 (2–411
amino acids) was gifted from Dr. John Tainer (Lawrence Berkeley National
Laboratory, USA). With C-terminal his tag, human Nbs1 (F4; 622–729 amino
acids) was constructed in pMAL vector (New England Biolabs) for N-terminal
MBP tag for its solubility. See Supplemental Experimental Procedures for the
purification, EMSA, and nuclease assay.
SFM Analysis
For SFM analysis of MR/NBS1 F4-WT or -mid5 complexes, Mre11-Rad50
(MR) protein and Nbs1 F4 fragment were mixed in reaction buffer (20 mM
Tris-HCl [pH 8], 0.1 M EDTA, 0.2 M NaCl, and 2 mM DTT) at a molar ratio1:1 (8 nMofMR to 8 nMF4-WT or -mid5) in total volume of 20 mL and incubated
for 5 min on ice. The samples were then diluted five times in final volume of
20 mL in reaction buffer and deposited on freshly cleaved mica. After a 1-min
incubation at room temperature, the mica was washed with milliQ water and
dried with filtered air. Samples were imaged at room temperature and humidity
with a Nanoscope VIII (Digital Instruments) operating in tapping mode. Type
NHC-W silicon tips with resonance frequency 310–372 kHz were obtained
from Nanosensors (Veeco Instruments). Images were collected at 2.5 3
2.5 mm, standard resolution 512 lines 3 512 rows, and processed only by flat-
tening to remove background slope. Images were quantified first by identifying
MR complexes by visual inspection where molecules consisting a large glob-
ular domain with two protruding coiled coils were identified as M2R2. These
were further classified based on the arrangement of globular domains as
dimers with one globular domain or dimers with two distinct linked globular
domains. The latter were further categorized according to the arrangement
of coiled coils as open, parallel, or hook-linked. The frequency of the different
forms was expressed as percentage of total molecules counted. The width of
individual globular domains was determined using SFMetrics V4e software
(Sa´nchez and Wyman, 2015) by manually measuring the longest axis across
the globular domain.
Statistical Analysis
Statistical significance was analyzed by unpaired t test, Fisher’s exact test, or
Wilcoxon rank sum test and expressed as a p value as indicated in the figure
legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.12.035.
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Figure S1. TALEN targeting for Nbs1mid mutant mouse lines, Related to Figure1.
(A) Binding sites of two recombinant TALE nucleases (TALEN) targeting Mre11-interacting domain 2 
of mouse Nbs1 gene. (B) Examples of genomic sequences of Nbs1mid mutant mouse lines. Binding 
sites of two recombinant TALEN are indicated in blue color. XmnI restriction enzyme site that was 
used for initial diagnosis of gene editing by TALEN is indicated in red color. The sequence of 
Mre11 interacting domain 2 is indicated in green color.
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Figure S2. G2/M checkpoint and IR sensitivity of Nbs1mid mutants cells, Related to Figure 2.
(A) Analysis of G2/M checkpoint in Nbs1mid3 and Nbs1mid4 SV40-MEFs. Mitotic cells were 
detected by measuring mitosis-speciﬁc phosphorylation of histone H3 (Ser10). P-value 
was determined by unpaired t-test (*p<0.05, mean ± s.d., Two or three independent 
experiments in triplicate). (B) Colony formation assay to determine the DNA damage sensitivity. 
Nbs1mid3 and Nbs1mid4 SV40-MEFs treated by different dose of IR were grown for 10 days and 
survived colonies were counted. P-value was determined by unpaired t-test (*p<0.05, ***p<0.001, 
mean ± s.d., Two or three independent experiments in triplicate). (A and B) WT SV40-MEFs 
generated with littermate embryo of each genotype were used for comparison.  (C) ATM signaling 
in Nbs1-/mid8 SV40-MEFs was assessed by Western blot for the phosphorylation of ATM substrates, 
KAP1 (S824) and Chk2, after IR treatment. (D) Analysis of G2/M checkpoint in Nbs1-/mid5 and 
Nbs1-/mid8 SV40-MEFs. Mitotic cells were detected by measuring mitosis-speciﬁc phosphorylation 
of histone H3 (Ser10). Nbs1+/mid8, Nbs1-/-, ATM-/- SV40-MEFs were used for controls. P-value was 
determined by unpaired t-test (***p<0.001, mean ± s.d., n=3).
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Figure S3. Veriﬁcation and analysis of rescue cell lines, Related to Figure 3.
(A) Nbs1F allele and genotype PCR primers are indicated. Primers are indicated in red arrow 
and sequences were previously described (Frappart et al., 2005). (B) PCR genotyping of Nbs1-/- 
rescue cells. (C) Expression of rescue fragments was shown by Western blot using anti-Flag 
antibody. (D) IR-induced p-Kap1(S824) was assessed in the absence or presence of KU-55933 
ATM inhibitor (10 μM 1 hr pretreated). Nbs1 level shows the absence of endogenous Nbs1 in 
Nbs1-/- + F4 cells. Colony formation assay to determine the DNA damage sensitivity of Nbs-/-+ F2 
and Nbs-/-+ F4 SV40-MEFs. Parental NbsF/F SV40-MEFs were used for comparison. Cells treated 
with different dose of IR were grown for 10 days and survived colonies were counted. P-value 
was determined by unpaired t-test (*p<0.05 for NbsF/F vs. Nbs-/-+ F2; **p<0.01 for Nbs-/-+ F2 vs. 
Nbs-/-+ F4, mean ± s.d., Two independent experiments in triplicate). 
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Figure S4. Mre11-NLS expression fails to rescue Nbs1 deﬁciency, Related to Figure 3.
(A) Immunoﬂuorescence cell staining of Mre11-NLS in Nbs1-/- SV40-MEFs. Nbs1 deﬁciency was 
achieved by cre induction acutely. Nuclei are shown by DAPI (4’,6-diamidino-2-phenylindole) 
staining. (B) IR-induced G2/M cell cycle checkpoint of Nbs1-/--Mre11-NLS SV40-MEFs. Mitotic 
cells were detected by measuring mitosis-speciﬁc phosphorylation of histone H3 (Ser10). Three
independent clones of Nbs1-/--Mre11-NLS SV40-MEFs were analyzed and combined for graph 
presentation. P-value was determined by unpaired t-test (ns: not signiﬁcant).
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Figure S5. Gel ﬁltration of Mre11 and Nbs1-F4 complex by Superdex 200, Related to Figure 4. 
Equimolar mixture of human Mre11 (1-411aa) and WT or mid5 Nbs1-F4 protein were used at 
0.5 μM. Elution fractions were visualized by Western blot using His antibody. Molecular weight 
was estimated by gel ﬁltration standard.
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Figure S6. Hemavet quantiﬁcation of whole blood cell numbers from 12 days-old 
Nbs1-/+ vavCre  and Nbs1-/- vavCre mice, Related to Figure 6. Peripheral blood from mouse 
of each genotype was obtained from the tail vein and complete blood cell analysis was 
performed on Hemavet (Drew Scientiﬁc). WBC= white blood cells, RBC=red blood cells.
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case Sex Age (days) Histological types
1 male 102 lymphoma
2 female 117 ND
3 female 123 lymphoma
4 male 145 lymphoma
5 female 152 lymphoma
6 female 165 lymphoma
7 female 173 lymphoma
8 male 180 lymphoma
9 female 181 ND
10 female 188 lymphoma
11 male 194 lymphoma
12 male 200 lymphoma
13 female 209 lymphoma
14 male 212 lymphoma
15 male 266 lymphoma
case Sex Age (days) Histological types
1 male 67 leiomyosarcoma
2 male 90 lymphoma
3 female 126 lymphoma, squamous cell carcinoma
4 male 127 lymphoma
5 female 128 lymphoma
6 male 131 lymphoma
7 male 135 lymphoma
8 female 156 lymphoma
9 male 162 lymphoma
10 male 167 lymphoma
case Sex Age (days) Histological types
1 male 76 lymphoma
2 male 95 lymphoma
3 male 97 lymphoma
4 female 102 lymphoma
5 male 110 hemangiosarcoma
6 male 111 lymphoma
7 male 124 lymphoma
8 male 129 lymphoma
9 male 140 lymphoma
10 male 154 lymphoma
11 female 154 lymphoma
12 male 159 rhabdomyosarcoma
13 male 161 lymphoma
14 male 162 lymphoma
15 female 170 lymphoma
16 male 176 lymphoma
17 male 181 histiocytic sarcoma
18 male 186 lymphoma
19 male 186 lymphoma
20 male 195 ND
Table S1. Pathology of Nbs1+/+ p53-/-, Nbs1mid3/mid3 p53-/-  and Nbs1mid4/mid4 p53-/- mice, 
Related to Figure 2.
ND : not determined. 
Supplemental Experimental Procedures 
Cell lines 
Primary mouse embryonic fibroblasts (MEFs) were derived from E13.5 embryos 
and maintained in DMEM/10% fetal bovine serum/antibiotics. SV40 transformed MEFs 
were maintained in DMEM/10% cosmic calf serum.  
Inducible MEFs were derived by crossing of Nbs1+/mid5 or mid8 mice with Nbs1F 
mice. MEFs in which deletion of Nbs1F allele is 4-hydroxytamoxifen (4-OHT) inducible 
were generated by stable expression of MSCV CreERT2 puro (a gift from Tyler Jacks; 
Addgene plasmid #22776). Deletion was carried out by 1 day exposure with 100 nM 4-
OHT treatment followed by removal for additional 3 days to minimize Cre toxicity. 
Nbs-/F SV40-MEFs were kindly provided by Titia de Lange (Rockefeller 
University, USA). 
Rescue cells were generated by expression of Flag-SV40 NLS (PKKKRKV) 
containing Nbs1 fragments followed by deletion of endogenous Nbs1F allele.  Nbs1 
fragments were cloned into pMIG-W-IRES-GFP plasmid (a gift from Luk Parjis; 
Addgene plasmid #12282).  Deletion of endogenous Nbs1F allele and expression of 
exogenous Nbs1 fragments were confirmed by Western blot and PCR genotyping. 
Mre11-NLS construct was made by insertion of 2 copies SV40 NLS (PKKKRKV) at C 
terminus of Mre11 cDNA. 
Cellular assay 
Immunoprecipitaions (IP) were performed with 500 µg of Flag-tagged Nbs1 
expressing cells extracts using 1X PBS/0.5% (v/v) TritonX-100/400 mM NaCl/Protease 
inhibitor cocktail buffer (Roche). Flag peptide (F3290, Sigma) was added to WT sample 
at 100 µg/ml for a Flag IP control. 
Western blots were carried out by standard protocol. Briefly, total cell extracts 
were prepared in SDS lysis buffer (60 mM Tris-HCl pH 6.8, 2% SDS) and 20-40 µg of 
extracts were analyzed with specific antibodies. Antibodies used in this study were 
Mre11 (custom made), Nbs1 (custom made), Rad50 (custom made), p-Kap1 S824 
(ab70369, Abcam), total Kap1 (NB500-159, Novus), Chk2 (05-649, Millipore), p-ATM 
S1981 (#4526L, Cell signaling), total ATM (#2873S, Cell signaling), and Flag (F3165, 
Sigma). 
G2M cell cycle checkpoint assay was performed by flow cytometry measuring 
Ser10 phosphorylation of histone H3 with anti-phospho-Ser10-Histone H3 antibody 
(06-570, Millipore) 1 hr after 3 Gy of IR exposure.  
For colony formation assay, cells were plated with different IR treatments and 
cultured for 10 days. Colonies were visualized by crystal violet stain and counted.  
For micronuclei staining, cells were fixed with 4% (v/v) formaldehyde in PBS for 
15 min at RT and permeabilized in PBS containing 0.5% (v/v) TritonX-100. Cells were 
mounted with ProLong® Gold Antifade DAPI-Mountant (Life technologies). 
For metaphase spread, cells were treated with 100 ng/ml of KaryoMAX colcemid 
(Life technologies) for 1 hr and harvested. Cells were swelled in 0.075 M KCl for 15 min 
at 37°C and fixed in ice-cold 3:1(v/v) methanol: acetic acid. Dropped samples on slides 
were stained with 5% Giemsa (Sigma) and mounted with Permount medium (Fisher 
Scientific). More than 40 spreads were analyzed per each sample.  
Fetal liver cell (FLC) transplantation 
For donor FLCs, fetal liver cells were isolated from E13.5 Nbs1F/FvavCre embryos 
and red blood cells were lyzed in ACK lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 
mM EDTA). FLCs were maintained in FLC media (DMEM-IMDM1:1/10% FBS/4 mM L-
glutamine/50 mM β-mercaptoethanol, 10 ng/ml IL-3, 10 ng/ml IL-6, 20 ng/ml SCF). For 
transplantation, donor Nbs1F/FvavCre FLCs were infected by spin infection (1800 rpm 
for 45 min with 8 µg/ml of polybrene) with retrovirus expressing Nbs1 fragment-IRES-
GFP. As the viability of Nbs1F/FvavCre FLCs dropped during the culture after isolation, 
cells were infected and cultured only for 3 days before transplantation. Due to the 
mouse strain of donor Nbs1F/FvavCre FLCs, we used F1 hybrid of C57BL/6 x 129 as a 
recipient. Briefly, 6-week old F1 hybrid mice were irradiated at lethal dose (5 Gy x 2 
times) and 3×105 FLCs were transplanted via tail vein injection. After 10 weeks post 
transplantation, thymocytes and splenocytes were isolated and analyzed to assess 
GFP+ cells that were derived from donor FLCs expressing Nbs1 fragment-IRES-GFP. 
Rescued cells by Nbs1 fragment-IRES-GFP were confirmed by flow cytometry and 
PCR genotyping using primers for vavCre or exogenous Nbs1 rescue fragments that 
are specific for donor cells. Primers for PCR genotyping are vavCre allele and Nbs1 
rescue fragments are 5’-CAAGTGACAGCAATGCTGTTTCAC-3’, 5’-
CAGGTATCTCTGACCAGAGTCATC-3’ for Cre and 5’-
CAGTGAGGAGCTGCCACGGAAACT-3’, 5’-TCTAACTCGGTATTCTTTCGAGCATGGT-
3’ for Nbs1 rescue fragments. 
Protein purification and analysis 
Bacterial expression vector for N-terminal his-tagged human Mre11 (2-411aa) 
was gifted from Dr. John Tainer (Lawrence Berkeley National Laboratory, USA). With C-
terminal his-tag, human Nbs1 (F4, 622-729aa) was constructed in pMAL vector (New 
England BioLabs) for N-terminal MBP-tag for its solubility.  
For purification, Mre11 protein was purified by serial FPLC purification using 
HisTRAP (GE Healthcare) and HiTRAP Q FF (GE Healthcare) column followed by 
Superdex S200 (GE Heathcare) gel filtration. FPLC running buffers are; 20 mM Tris-HCl 
pH8, 0.5 M NaCl, 0.5 mM DTT, 5 mM imidazole for HisTRAP; 20 mM Tris-HCl pH 8, 0.1 
mM EDTA, 2 mM DTT for HiTRAP Q FF ; 20 mM Tris-HCl pH 8, 0.1 mM EDTA, 0.2 M 
NaCl, and 2 mM DTT for Superdex S200. Nbs1 proteins were purified by batch affinity 
purification methods using amylose resin (New England BioLabs) followed by Nickel-
affinity purification (Qiagen) by manufacturer’s standard protocol. Then, the samples 
were subject to FPLC Superdex S200 gel filtration to remove imidazole from the elution 
buffer. Mre11 and Nbs1 proteins were eluted at the single peak as a monomer at the 
given gel filtration condition.   
For electrophoretic mobility shift assay (EMSA), the indicated amounts of 
purified Mre11 and Nbs1 proteins were incubated with 32P-end labeled dsDNA or 
hairpin DNA probe in the binding condition of 25 mM Tris-HCl pH8, 100 mM NaCl, 1 
mM DTT for 20 min at RT. The sequences of ds DNA is 5’-
GTCTTCAGGACAGCAGTGAGGAGAACCCACGGAAACTGCTGCTGACTGA-3’, and 
hairpin is 50 nt (DAR134) previously used (Paull and Gellert, 1998). The reactions were 
loaded in to 5% native-PAGE and run for 1hr at 200 V in 0.5x TBE buffer. After drying 
gel, the probes in the gel were visualized by phosphorimager (Fujifilm). For supershift, 1 
µg of MBP (sc-32747, Santa Cruz) or control antibodies (sc-2025, Santa Cruz) were 
preincubated 10 min at RT before adding DNA probe. 
Nuclease assay 
Nuclease assay were performed as described in previous literatures (Anand et 
al., 2016; Cannavo and Cejka, 2014). Briefly, 3’-end radiolabelled 1 nM of biotinylated 
70 bp-long DNA oligonucleotide substrates were incubated with streptavidin (15 nM, 
Sigma) to block the ends of substrates.  Purified recombinant proteins were then 
added to the reaction for 30 min at 30°C in nuclease reaction buffer containing 25 mM 
Tris-acetate pH 7.5, 25 mM Manganese acetate, 1 mM Magnesium acetate, 5 mM 
Dithiothreitol, 1 mM ATP, 1 mM Bovine serum albumin (New England Biolabs), 0.25 
mg/ml Phosphoenolpyruvate, and 1 mM Pyruvate kinase (Sigma).  Reaction products 
were analyzed on 15 % polyacrylamide denaturing urea gels (19:1 acrylamide-
bisacrylamide, Bio Rad) and scanned by Typhoon phosphor imager (GE Healthcare). 
Immunofluorescence staining 
Cells were fixed with 4% (v/v) formaldehyde in PBS for 15 min at RT and 
permeabilized in PBS containing 0.5% (v/v) TritonX-100. All staining were done with 
PBS buffer containing 1% BSA, 0.1% (v/v) Tween 20. Primary antibodies were used at 
1:10000 (Mre11; custom made) or 1:2000 (Rad50; IHC-00076, Bethyl) and secondary 
antibodies (Alex Fluor-594; Life technologies) were used at 1:1000 dilutions. Cells were 
mounted with ProLong® Gold Antifade DAPI-Mountant (Life technologies). 
Histopathology  
Tissue samples from the sacrificed mice were fixed with 4% (v/v) formaldehyde 
overnight at 4°C and stored at 4°C in 70% ethanol. Paraffin embedded samples were 
prepared by eight-micrometer section and were subjected to pathological analysis 
after Hematoxylin and eosin (H&E) staining. All sample preparation and pathological 
analysis were performed by Histoserv, Inc. (Maryland, USA). 
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